Previous Article
Molecular and Cellular Biology, August 2001, p. 5688-5697, Vol. 21, No. 16
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.16.5688-5697.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
A Murine Homologue of the Drosophila
brainiac Gene Shows Homology to Glycosyltransferases and Is
Required for Preimplantation Development of the Mouse
Benedikt
Vollrath,
Kevin J.
Fitzgerald,
and
Philip
Leder*
Howard Hughes Medical Institute and
Department of Genetics, Harvard Medical School, Boston,
Massachusetts 02115
Received 5 March 2001/Returned for modification 6 April
2001/Accepted 23 May 2001
 |
ABSTRACT |
The neurogenic gene brainiac was first isolated in
Drosophila melanogaster, where it interacts genetically
with members of the Notch signaling cascade. We have isolated a murine
homologue of the Drosophila brainiac gene and delineated
its highly specific expression pattern during development and adult
life. We find particularly strong expression in the developing central
nervous system, in the developing retina, and in the adult hippocampus. Targeted deletion of mouse Brainiac 1 expression leads to
embryonic lethality prior to implantation. Null embryos can be
recovered as blastocysts but do not appear to implant, indicating that
mouse Brainiac 1, likely a glycosyltransferase, is crucial for very early development of the mouse embryo.
 |
INTRODUCTION |
The Notch signaling pathway has been
implicated in cell fate decisions in a variety of developmental
contexts in Drosophila melanogaster, Caenorhabditis elegans,
and vertebrates (4, 22, 52). Notch-dependent
signaling events include the induction of cell fates by cell-cell
interaction (a process termed "lateral specification"), as well as
the formation and maintenance of epithelial cell layers.
Notch encodes a transmembrane receptor that binds to the
membrane-bound ligands Delta and Serrate. Upon ligand
binding, Notch is cleaved by an unknown mechanism and an
intracellular portion of the molecule translocates together with the
Suppressor of Hairless [Su(H)] gene product to the nucleus, where the
protein complex acts as a transcriptional activator (34,
50). Genetic evidence from Drosophila indicates that
the genes of the Enhancer of split [E(spl)]
complex, which encode basic helix-loop-helix proteins, are targets of
the Notch signaling cascade (6, 13, 31, 37). Homologues of
Notch signaling molecules have been isolated in Xenopus
laevis, mice, and humans and demonstrate a high degree of
conservation of the Notch signaling cascade (23, 35, 45).
As in Drosophila, Notch signaling in vertebrates is involved
in cell fate specifications in a variety of developmental processes.
The neurogenic gene brainiac has been isolated in
Drosophila in screens for female sterile or larval lethal
mutations and has been shown to be involved in lateral specification
and epithelial morphogenesis (21). brainiac
mutant flies produce offspring with a neural hyperplasia and epidermal
hypoplasia reminiscent of hypomorphic Notch, Delta, or
E(spl) alleles, and genetic evidence indicates that
brainiac acts in the same genetic pathway as
Notch (21). However, in contrast to
Notch loss-of-function mutations, brainiac mutant
flies do not exhibit altered cell fate specifications during
oogenesis or development of the peripheral nervous system, suggesting that the brainiac gene product is only involved
in a subset of Notch signaling events in Drosophila.
Loss-of-function brainiac mutations in Drosophila
cause follicular epithelial cells surrounding the oocyte to lose their
epithelial morphology and to acquire a mesenchyme-like shape (18,
19), a phenotype also associated with hypomorphic
Notch alleles (53). The follicular epithelium
shows loss of epithelial polarity and aberrant cytoskeletal architecture in brainiac mutant flies, and cells accumulate
in multiple layers at the posterior end of the oocyte.
brainiac mutant flies frequently have discontinuities in the
follicular epithelium, presumably caused by a failure of follicle cells
to migrate over the top of or adhere to germ cells during early
follicular development. brainiac has been shown to act cell
nonautonomously in Drosophila, suggesting that brainiac
acts on proteins on their transport through the secretory pathway or
that brainiac itself is secreted.
In addition to its relationship with Notch signal transduction,
brainiac has also been shown to cooperate with the epidermal growth factor (EGF) receptor pathway during morphogenesis of the follicular epithelium in the Drosophila ovary (19,
21). brainiac mutant flies show aberrant
dorsal-ventral patterning during oogenesis and show genetic interaction
with gurken (the Drosophila homologue of
transforming growth factor
[TGF-
]), and the EGF
receptor (19, 21).
Genetic evidence indicates that brainiac shares features
with fringe, a gene involved in defining dorsal-ventral
boundaries during formation of the Drosophila wing and the
vertebrate limb (20, 29, 36, 46). Both fringe and
brainiac are involved in regulating a subset of
Notch-dependent signaling events and also possess
significant sequence homology to glycosyltransferases, suggesting that
glycosylation of either Notch or its ligands modulates their
interactions (11, 25, 41, 56). Recent evidence shows convincingly that Drosophila and vertebrate Fringe proteins
are indeed glycosyltranferases modifying Notch itself and that
this glycosylation event modulates Notch-Delta interactions (9, 40).
Evidence from Drosophila shows that brainiac is
an important modulator of signaling and/or cell adhesion events during
embryonic development of the fly. In this report, we describe the
functional characterization of a putative murine homologue of the
Drosophila brainiac gene. Mouse Brainiac 1 is
expressed in the central nervous system (CNS) during development and
adult life. We eliminated Brainiac 1 expression by targeted
deletion in embryonic stem (ES) cells and show that Brainiac
1 is essential for preimplantation development of the mouse embryo.
 |
MATERIALS AND METHODS |
Isolation of murine brainiac cDNA and genomic clones
and construction of a targeting vector.
To isolate a murine
homologue of the Drosophila brainiac gene, we screened the
EST database for vertebrate homologues using the BLAST algorithm. EST
clone yr97d07.r1 (Genome Systems), derived from a human spleen and
kidney library, possessed the highest sequence homology (at the protein
level) to Drosophila brainiac of any vertebrate sequence
found in the database at that time. The full-length cDNA insert of this
clone was used to screen a mouse 17.5-day-postcoitus (d.p.c.) embryonic
library (Clontech) using standard procedures.
An 836-bp cDNA fragment encoding amino acids 31 to 310 of the murine
Brainiac 1 gene was used as a probe to screen a mouse 129/SvEv genomic BAC library (Genome Systems). Three positive clones
were isolated, and restriction mapped using Southern blot hybridization
and the 836-bp mouse Brainiac 1 cDNA probe. All three BAC
clones contained an equivalent mouse Brainiac genomic fragment. One BAC clone was used to subclone EcoRI and
HindIII genomic fragments of approximately 10 to 12 kbp
into pBluescript (Stratagene). Both genomic subclones were restriction
mapped using Southern blot hybridization with oligonucleotides
corresponding to various regions of the mouse Brainiac 1 coding sequence.
Targeted disruption of mouse Brainiac in ES cells and
generation of Brainiac chimeric mice.
A targeting
vector (pmbrn11) was constructed in pOSdupdel (a gift kindly
provided by O. Smithies), which contains an MCl-neo cassette (flanked
by LoxP sites) for positive selection and an outside PGK-TK cassette
for negative selection with FIAU. Adjacent genomic HincII
fragments of 6 and 2 kb were ligated into the blunted XhoI
site and the HpaI site, respectively, of the vector. This construct inserts the PGK-neo cassette into the Brainiac 1 coding sequence 140 bp 3' of the start codon, with transcription of
neo and Brainiac 1 occurring in the same direction.
TC1 ES cells derived from 129/SvEv mice were electroporated with
NotI-linearized p
mbrn11 and selected with G418
and FIAU as
described previously (
14). G418- and
FIAU-resistant clones were
isolated and propagated in 24-well tissue
culture dishes. Genomic
DNA was isolated from these clones as described
elsewhere (
15)
and sceened for targeting by digestion with
EcoRI and
AscI, followed
by Southern blot
analysis using standard conditions. Blots were
hybridized with a 1-kbp
BanI-
AccI fragment (isolated from a BAC
subclone)
located 3' of the genomic region used to construct the
targeting
vector. After screening 230 G418- and FIAU-resistant
colonies, we
isolated one ES cell clone showing proper genomic
rearrangement at the
mouse
Brainiac 1 locus. This positive ES
cell clone was
microinjected into C57BL/6J blastocysts, which
were subsequently
transferred into pseudopregnant Swiss Webster
foster mothers (Taconic).
We obtained two male and one female
high-grade chimeric mice, as judged
by agouti coat color. Chimeras
were mated to 129/SvEv or NIH Bl/SW mice
(Taconic), and germ line
transmission was confirmed by Southern blot
analysis. As expected,
the two male chimeric mice showed germ line
transmission of the
introduced
Brainiac 1 mutation,
while the female chimera did not.
Heterozygote offspring from this
F
1 cross were intercrossed to
derive the mouse
colony.
PCR genotyping was performed using the following primers:
mbrn1koF (5'-GGT GAT ATG GTA CCT CAG CCT CCC CCA CTA
C-3'),
mbrn1koR
(5'-GTG AGG TCA CCA GGA TGA CCA
GGA ATG GG-3'), and neoR (5'-AAT
GAC AAG ACG CTG GGC GGG GTT
TGC TCG-3'). Reactions were performed
with
Taq
polymerase (Boehringer Mannheim) in 50-µl total volume,
with all
three primers simultaneously present at 200 nM each.
Primary
denaturation was performed at 94°C for 5 min, followed
by 40 cycles
of 94°C for 1 min, 65°C for 1 min, and 72°C for 1
min. Reaction
products were analyzed on 2.2% agarose gels. The
wild-type allele
(product
mbrn1koF-
mbrn1koR) was expected to give
a PCR product of 166 bp, while the mutant allele (product
mbrn1koF-neoR)
was expected to give a PCR product of 280
bp.
Isolation and genotyping of bastocysts.
To isolate
blastocysts, female Brainiac 1 heterozygote animals were
superovulated with pregnant mare serum (PMS) and human chorionic
gonatotrophin (HGG) and mated to Brainiac 1 heterozygote males. Blastocysts were isolated at 3.5 d.p.c. by flushing the uterus with CMRL-1066 medium (Gibco) containing 10% heat-inactivated fetal calf serum. Blastocysts were then cultured in 24-well tissue culture dishes at 37°C in CMRL-1066-10% heat-inactivated fetal calf
serum-10x MEM Nonessential Amino Acids (Gibco), 10 mM
L-glutamine (PenStrep; Gibco).
For genotyping, blastocysts were transferred to PCR tubes and lysed in
10 ml of 100 mM Tris (pH 8.0)-5 mM EDTA-0.2% sodium
dodecyl sulfate
(SDS)-200 mM NaCl-220 mg of proteinase K (Boehringer
Mannheim) per ml
overnight at 50°C. The proteinase K was heat-inactivated
at 94°C
for 159 min. Then, 2 µl of lysate was subjected to 50
cycles of PCR
using the primers and conditions described above.
PCR products were
analyzed on 2.2% agarose gels. For blastocysts
at stage 3.5 d.p.c., two separate reactions were performed using
primer pairs
mbrn1koF-
mbrn1koR and
mbrn1koF-neoR,
respectively.
PCR products were visualized by Southern blot
hybridization using
the following probes: the 836-bp mouse
Brainiac 1 cDNA and a 280-bp
mutant PCR product amplified
from the targeting vector with
mbrn1koR
and
neoR.
Northern blot analysis.
Total cytoplasmic RNA was isolated
from cell lines or tissues using RNA STAT (Tel-Test, Inc.), and mRNA
was prepared using magnetic poly(T) beads according to the
manufacturer's protocols (Boehringer Mannheim). Next, 2 µg of mRNA
was loaded on to a 1% agarose gel containing formaldehyde. After
electrophoresis, the mRNA was blotted onto GeneScreen Plus membranes
(NEN) and hybridized using standard procedures (5). A
murine glyceraldehyde-3-phosphate dehydrogenase (GAPDH) full-length
cDNA was used as a loading control.
In situ hybridization.
For in situ hybridizations on tissue
sections, tissues or embryos were fixed overnight in 4% formaldehyde.
For P10 and adult brains, animals were perfused first with ice-cold
phosphate-buffered saline (PBS) and then with 4% formaldehyde prior to
fixation. After fixation, tissues were dehydrated in ethanol and
mounted in paraffin. Samples were sectioned on a microtome
(Reichert-Jung; 8-µm sections) and layered on glass microscope
slides. Sections were dewaxed with xylene, treated for 7.5 min with
proteinase K (20 mg/ml), and postfixed with 4% formaldehyde.
Hybridizations were performed in 50% formamide-20 mM Tris (pH
7.4)-10% dextran sulfate-1× Denhardt's solution-10 mM
dithiothreitol (DTT)-0.5 mg of yeast tRNA per ml.
35S-labeled riboprobes were added to the hybridization
solution at 5 × 104 cpm/µl, and hybridizations were
performed overnight at 52°C. After hybridization, slides were washed
first with 5× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium
citrate)- 10 mM DTT at 50°C and then with 2× SSC-50%
formamide-10 mM DTT at 65°C and were finally treated with 20 µg of
RNase A per ml for 30 min at 37°C. Slides were then dehydrated with
ethanol and finally developed in NTP-2 photo emulsion (Kodak). Times of
exposure were estimated from signal intensities on Cornex films after
exposure overnight. Slides were developed using Kodak developer and
counterstained with either hematoxylin and eosin (ovaries and embryos)
or toluidine blue (brain sections) using standard procedures.
Control hybridizations were performed using a sense probe to
Brainiac 1. In no case could a signal above background be
detected
(data not
shown).
For whole-mount in situ hybridizations, embryos were dissected from
pregnant wild-type animals (FVB; Taconic) at various time
points of
pregnancy (8.5, 9.5, 10.5, and 12.5 d.p.c.) and fixed
overnight in
4% paraformaldehyde at 4°C. After fixation, embryos
were washed with
PBS-0.1% Tween 20 (PBT) several times at 4°C
and then dehydrated in
a series of methanol-PBT. After incubation
overnight in methanol, the
embryos were rehydrated in a series
of methanol-PBT, bleached with 6%
hydrogen peroxide, treated with
10 µg of proteinase K (Boehringer
Mannheim) per ml for 15 min
at room temperature, and washed with 2 mg
of glycine per ml in
PBT for 10 min at room temperature. Embryos were
then postfixed
with 4% paraformaldehyde and 0.2% glutaraldehyde in
PBT for 10
min, washed with PBT, and prehybridized in 50%
formamide-5× SSC
(pH 4.5)-1% SDS-50 µg of yeast RNA (Boehringer
Mannheim) per ml-50
µg of heparin per ml for at least 1 h at
70°C.
Mouse
Brainiac 1 riboprobes were digoxigenin (DIG)-labeled
using T7 and T3 RNA polymerases (DIG RNA Labeling Kit; Boehringer
Mannheim) and purified using ethanol precipitation. Embryos were
then
hybridized in 50% formamide, 5× SSC (pH 4.5), 1% SDS, 50
µg of
yeast RNA (Boehringer Mannheim) per ml, and 50 µg of heparin
per ml
overnight at 70°C.
After hybridization, embryos were washed in 50% formamide-5× SSC (pH
4.5)-1% SDS and blocked in 10% sheep serum-TBST, and
transcript was
detected using an anti-DIG antibody (Boehringer
Mannheim) and nitroblue
tetrazolium-BCIP (5-bromo-4-chloro-3-indolylphosphate)
staining.
 |
RESULTS |
Isolation of a mouse homologue of the Drosophila
brainiac gene.
We identified a putative murine homologue of
the Drosophila brainiac gene, which we termed mouse
Brainiac 1 (Mbrn 1), encoding a protein of 332 amino acids, with a predicted size of 39.4 kDa. The sequence isolated
here proved to be identical to the murine
3-GalT-III gene
identified recently in an EST database search using human
-galactosyltransferase as the reference sequence (24).
Drosophila brainiac and the mouse homologue Brainiac
1 share several regions of high sequence similarity, although the overall sequence identity between the two proteins is only ca. 34%
(Fig. 1A). Interestingly, these domains
are also highly conserved among different murine
1,3-galactosyltransferase family members but are not found in
1,4- or
1,3-galactosyltransferases (Fig. 1B). Biochemical
analysis performed by others showed that mouse Brainiac 1 does indeed specifically catalyze
1,3 links between galactose and
N-acetylglucosamine (24). One of the conserved domains (domain 3, Fig. 1B) contains an (E/D)DVXXG motif that has also
been found in bacterial galactosyltransferases and may be associated
with a catalytic domain (56). These data suggest that
Drosophila brainiac and its homologues in higher organisms belong to the same family of
1,3-galactosyltransferases.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Alignment of Drosophila brainiac (upper
sequence) and mouse Brainiac 1 (lower sequence). Identical
amino acids are boxed. Regions showing a high degree of homology
between mouse Brainiac 1 and members of the
3-GalT gene family are marked by a line above the
sequence. (B) Alignment of domains conserved in murine
3-GalT genes and Drosophila brainiac. The
regions showing high sequence similarity include an (E/D)DVXXG motif
that has also been found in bacterial galactosyltransferases.
|
|
In an expression study of adult mouse tissues by Northern blot
analysis, we detected a specific transcript of approximately
2 kb in
brain, kidney, lung, and ovaries, as well as in whole
16.5-d.p.c.
embryos (Fig.
2A), while all other
tissues examined
expressed extremely low amounts of the transcript. The
size of
the transcript is consistent with the cDNA sequence described
above. Because of the established role of the
Drosophila
brainiac gene in oogenesis and neurogenesis, we focused our
expression
analysis in the mouse on the ovaries and the CNS.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of mouse Brainiac 1 in adult mouse
tissues and the developing embryo. (A) Northern blot analysis of murine
tissues reveals specific expression of a 2-kb transcript. (B)
Expression of mouse Brainiac 1 in adult mouse ovaries
analyzed by in situ hybridization. The dark-field micrograph shows the
expression of mouse Brainiac 1 in follicular granulosa cells
in a stage-specific fashion: later-stage follicles with multiple layers
of granulosa cells show strong expression of mouse Brainiac
1 (white arrow), while the earlier-stage follicles with single
layers of granulosa cells show no expression (black arrow). Control
experiments with sense probes were negative (data not shown). (C)
Whole-mount in situ hybridization at 12.5 d.p.c. of gestation
shows strong expression of mouse Brainiac 1 in the limb buds
(arrows).
|
|
Mouse Brainiac 1 is expressed in ovarian granulosa
cells in a stage-specific manner.
Using in situ hybridization on
formalin-fixed sections of murine ovaries, we found mouse
Brainiac 1 to be specifically expressed in follicular
granulosa cells (Fig. 2B). Interestingly, expression of mouse
Brainiac 1 appeared to be highly dependent on the stage of
development of the follicle. While follicles containing only a single
layer of tightly adhered granulosa cells did not express Brainiac
1, very high expression was exhibited in follicles at later
developmental stages in which granulosa cells adhere less tightly to
each other (Fig. 2B). Since the Drosophila brainiac gene has
been shown to be important in establishing cell adhesion between
follicular epithelial cells and germ cells during oocyte development,
it is possible that mouse Brainiac 1 has a similar function
during murine follicular development and modulates the adhesion
properties of granulosa cells.
Expression of mouse Brainiac 1 during development.
To establish the temporal and spatial distribution of mouse
Brainiac 1 transcript during embryogenesis and adult
life, we performed in situ hybridization on paraffin sections of mouse embryos and tissues.
In 11.5-d.p.c. embryos, we failed to detect a specific signal above
background (data not shown). At day 12.5 of gestation,
Brainiac
1 transcript could be detected in all four ventricles
of the
developing brain. At this stage of development,
Brainiac 1 transcript was present in the ventricular zone, as well as in
the
mantle zone, although the signal appeared to be higher in
the outer
layers of the developing ventricles (Fig.
3A and
B).
An equivalent expression pattern in
the developing CNS was detected
at 14.5 d.p.c. (data not shown).
This observation suggests that
mouse
Brainiac 1 is primarily
associated with postmitotic cells
during the development of the CNS.
Thus, mouse
Brainiac 1 expression
appears to be upregulated
when neuroepithelial cells exit the
cell cycle and migrate toward the
outer layers of the developing
brain. This pattern is consistent with
expression data from the
P19 cell line, which has been used as an in
vitro model for neurogenesis
(
33,
42). P19 cells express
Brainiac 1 as undifferentiated
precursor cells and at higher
levels after retinoic acid-induced
differentiation into neurons and
glia (data not shown). In addition
to this expression pattern in the
CNS, we detected strong
Brainiac 1 expression in the limb
buds of developing embryos at 12.5 d.p.c.
(Fig.
2C).

View larger version (108K):
[in this window]
[in a new window]
|
FIG. 3.
Analysis of mouse Brainiac 1 expression in
the CNS by in situ hybridization. Throughout the panel, standard
phase-contrast micrographs are on the left; dark-field micrographs show
the in situ hybridization signal on the right. (A and B) Expression of
mouse Brainiac 1 in the ventricles of the developing CNS at
day 12.5 of gestation. Expression in the mantle zone appears to be
higher than expression in the ventricular zone (B, arrow). (C to F)
Mouse Brainiac 1 is expressed in the ganglion cell layer (F,
arrow) of the developing retina at postnatal day 1. (G to H) Mouse
Brainiac 1 is expressed in the dentate gyrus and the CA
regions of the hippocampus at postnatal day 10. An identical expression
pattern was observed in the hippocampus at postnatal day 1. Control
experiments with sense probes were negative (data not shown).
|
|
At postnatal day 1, we detected mouse
Brainiac 1 transcript
throughout the brain. Particularly high expression of mouse
Brainiac 1 was observed in the developing retina (Fig.
3C to
F) and the
hippocampus (Fig.
3G and H). In the retina, the transcript
appeared
to be specifically localized to the ganglion cell layer (Fig.
3C to F). Lower amounts of transcript were detected in the outer
layers
of the retina. At this stage of development, the outer
layers of the
retina are proliferative, while the ganglion cell
layer and the inner
plexiform layer consist of postmitotic, differentiated
neuronal cells.
At postnatal day 1, we also detected particularly
strong expression of
Brainiac 1 in the hippocampus and the cerebral
cortex (data
not shown). The expression pattern at this stage
is equivalent to that
found at postnatal day 10 (see
below).
At postnatal day 10, mouse
Brainiac 1 transcript was again
detected throughout the brain. A particularly strong signal was
observed in the hippocampus (Fig.
3G and H), where mouse
Brainiac 1 transcript was specifically detected in all CA subfields, as
well as the dentate gyrus. Overall, the amount of mouse
Brainiac 1 transcript appeared to be lower in the adult brain sections
than
in the P1 or P10 sections. In adult brain,
Brainiac 1 was
predominantly expressed in the hippocampus, in a pattern equivalent
to
that observed in the hippocampus at stage P10 (data not
shown).
Targeted disruption of mouse Brainiac 1 leads to
embryonic lethality prior to implantation.
Analysis of the murine
Brainiac 1 locus revealed that the entire coding region of
the gene is contained in a single exon of 996 bp. We disrupted the
murine Brainiac 1 gene by inserting a PGK-neo cassette 140 bp downstream of the start codon using homologous recombination in ES
cells (Fig. 4). Since no splicing is
anticipated in the stretch of RNA derived from this exon, this
insertion of the targeting cassette is expected to abolish expression
of the entire carboxy-terminal portion of the protein, leaving only 47 amino acids under the control of the endogenous promoter. This lesion
is expected to result in a null allele. ES cells transfected with the
targeting vector were selected with G418 for the presence of the neo
cassette and with FIAU for the loss of the thymidine kinase gene
present in the vector backbone. An ES clone with targeted disruption of
the mouse Brainiac 1 gene, as judged by Southern blot
analysis, was microinjected into blastocysts, and chimeric mice were
generated after transfer into pseudopregnant Swiss Webster foster
mothers. Offspring from the F1 generation obtained from matings of male chimeras to NIH BL/SW outbred mice were used to generate the mouse colony.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 4.
(A) Genomic organization of the mouse Brainiac
1 gene and strategy for targeted deletion of mouse Brainiac
1. The coding region of mouse Brainiac 1 is contained
in a single exon. A PGK-neo cassette flanked by LoxP sites was inserted
140 bp downstream from the start codon. Arrows indicate the location of
the primers used for PCR genotyping. Thymidine kinase (PGK-TK) was used
for negative selection by FIAU. Restriction sites: A, AscI;
H2, HincII; H3, HindIII; RI,
EcoRI. (B) Southern blot of ES cell DNA digested with
EcoRI and AscI. The 3' external probe was used to
identify the targeted allele. (C) PCR assay used to genotype embryos
and adult mice.
|
|
Mouse
Brainiac 1 heterozygote animals are fully viable and
fertile and do not appear to have any gross abnormalities. The
oldest
animals in our colony have reached the age of 1 year now
without our
being able to detect any signs of
illness.
After analyzing over 300 adult mice obtained from F
1 or
later-generation heterozygote intercrosses, we failed to obtain a
single live null animal, indicating that
Brainiac 1 expression
is essential for development and survival (Table
1). In addition,
we never detected
perinatal lethality in litters from heterozygote
intercrosses,
indicating that targeted disruption of the mouse
Brainiac 1 gene leads to embryonic lethality.
Analysis of embryos at between 9.5 and 12.5 d.p.c also failed to
detect
Brainiac 1 null embryos, while heterozygote and
wild-type
animals were detected using Southern blot hybridization and
PCR
genotyping (Table
1). In addition, no resorbed embryos were
detected,
suggesting that death of
Brainiac 1 null embryos
occurs very early
in development, potentially prior to implantation. We
therefore
focused our attention on the earliest stage accessible to
analysis
by isolating blastocysts at 3.5 d.p.c.
Brainiac
1 heterozygote
females were superovulated using PMS and HCG and
mated to
Brainiac 1 heterozyote males. Blastocysts were
isolated at 3.5 d.p.c by
flushing the uterus. Blastocysts were
either genotyped directly
or cultivated in vitro for up to 5 days prior
to
genotyping.
At 3.5 d.p.c., blastocysts of all three genotypes could be
detected at the expected frequency (Table
1 and Fig.
5).
Brainiac 1 null
blastocysts had an easily detectable inner cell mass and
cavity and
were indistinguishable from blastocysts of wild-type
or heterozygote
littermates (Fig.
5). The cells of the inner cell
mass were clearly
adhered in
Brainiac 1 null embryos, suggesting
intact
cell-cell adhesion at this stage of development. In addition,
most
Brainiac 1 null embryos identified (four of five embryos)
at
this stage of development had hatched from the zona pellucida,
indicating that
Brainiac 1 null embryos are viable at
3.5 d.p.c.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 5.
Targeted deletion of mouse Brainiac 1 results
in preimplantation lethality. Blastocysts from Brainiac 1 heterozygote intercrosses isolated at 3.5 d.p.c. appear normal,
with a clearly developed inner cell mass and an inner cavity. (A)
Blastocyst genotyped as wild type. (B) Blastocyst genotyped as
Brainiac 1 null.
|
|
We failed to detect any
Brainiac null embryos after
cultivating blastocysts for 48 h in vitro. At this time point,
most embryos
have attached to the tissue culture dish, and the
trophoblast
layer begins to be develop. Embryos heterozygous for the
Brainiac 1 mutation or wild-type embryos could be detected
in addition
to a significant number of embryos that could not be
genotyped
at all. In most cases where we failed to obtain a clear
genotyping
result, the embryo had deteriorated significantly and had
not
attached to the tissue culture dish. This data suggests that
Brainiac 1 null embryos die in vivo by between 3.5 and
4.5 d.p.c.
 |
DISCUSSION |
In this study, we report the functional characterization of a
putative murine homologue of the Drosophila brainiac gene.
The mouse gene described here encodes a protein with significant
overall amino acid sequence similarity to the Drosophila
brainiac protein. Interestingly, regions that show the highest
protein sequence conservation between the fly and mouse proteins are
also highly conserved in
1,3-galactosyltransferases but not in
1,4- or
1,3-galactosyltransferases, suggesting that brainiac in
Drosophila and Brainiac-like molecules in higher
organisms belong to a family of
1,3-galactosyltransferase enzymes
(12). This suggestion is further supported by the identity of the gene isolated in our screen (for vertebrate Brainiac
homologues) with a gene isolated in a database screen (for
galactosyltransferases) which encodes in vitro
1,3-galactosyltransferase activity (24). Biochemical
analysis revealed that mouse Brainiac 1 does indeed have
glycosyltransferase activity in vitro and catalyzes the formation of
galactose
1,3-N-actetylglucosamine structures
(24). No
1,4 linkage was detected in these in vitro
assays, suggesting that the enzymatic activity is highly specific for
1,3 links. A homologous gene has also been isolated in humans but,
surprisingly, does not show any glycosyltransferase activity in vitro
with the substrates tested (2). Since brainiac
acts cell nonautonomously in Drosophila, the putative
glycosyltransferase activity suggests that Brainiac might regulate
signaling events and/or cell adhesion processes through specific
glycosylation of cell-surface proteins.
Protein glycosylation has been shown to be an important modulator of
cell surface events in a variety of contexts, and mice carrying
targeted deletions in several genes for glycosyltransferases have been
described (16). While the loss of some
glycosyltransferases appears to lead to embryonic or perinatal
lethality, other enzymes of this family are not essential for
development and survival (10, 27, 39, 44). Malignant
transformation and metastatic potential have also been associated with
alterations in protein glycosylation. Ectopic expression of a
1,4-N-acetylglucosaminyltransferase in a B16 mouse
melanoma cell line suppresses the metastatic potential of these cells
in syngeneic mice (55); This malignant property has been
shown to depend on aberrant E-cadherin glycosylation (54),
indicating a link between glycosylation events and cell adhesion. In
addition, ectopic expression of a
1,4-N-acetylglucosaminyltransferase in PC12 cells has
been shown to disrupt NGF/Trk signaling by inhibiting receptor
dimerization but not receptor phosphorylation, causing inhibition of
neuronal differentiation in these cells. This observation indicates
that specific glycosylation events of receptors can modulate signaling
events (26). Interestingly, ectopic expression of mouse
Brainiac 1 does not interfere with NGF-induced
differentiation in PC12 cells, suggesting that glycosyltransferases
have very specific targets and modify specific biological events (B. Vollrath and K. Fitzgerald, unpublished observations).
As demonstrated in this report, mouse Brainiac 1 shows
strong expression in the developing CNS and retina, two tissues where Notch signaling has been shown to regulate cell fate specifications during development. Although we find Brainiac 1 expression
in undifferentiated neuroepithelial cells, Brainiac 1 expression appears to be upregulated in regions containing postmitotic,
differentiated cells such as the ganglion cell layer in the retina or
the outer layers of the developing ventricles. Notch receptors and its
ligands are generally thought to be primarily expressed in
undifferentiated neuroepithelial cells in the developing CNS and retina
(7, 38). However, several genes involved in Notch signal
transduction, such as Manic and Radical fringe
are expressed in a pattern very similar to Brainiac 1 in the
developing CNS (11). In addition, there is some evidence
that Notch 1 is expressed in postmitotic neuronal cell
populations in the ganglion cell layer of the developing retina and in
the CNS and Notch 1 has been shown to regulate neurite outgrowth in differentiated, postmitotic neurons in vitro (1, 8,
47). In addition to the expression during retinal and CNS
development, mouse Brainiac 1 shows strong expression in the limb buds during embryogenesis; in this tissue Notch receptors and
their ligands are known to be expressed and function in pattern formation (48, 49).
Mouse Brainiac 1 also shows strong expression in the
follicular granulosa cells of the ovary in a stage-dependent fashion. Granulosa cells that adhere tightly in an organized monolayer of
epithelial cells show undetectable expression of mouse
Brainiac 1, while cells that have lost their cell-cell
adherence form less-organized multilayers in later-stage follicles and
have a high level of Brainiac 1 expression. Since
Drosophila brainiac has been implicated in regulating
cell-cell adhesion during oogenesis in the fly, it can be hypothesized
that mouse Brainiac 1-dependent glycosylation regulates the
adhesive properties of follicular granulosa cells in the mouse.
Our results suggest that Brainiac-dependent glycosylation events
are essential for murine development. Loss of Brainiac-dependent glycosylation through targeted deletion of the gene leads either to
implantation failure or to embryonic death prior to implantation. This
observation suggests that glycosylation events by members of the
Brainiac protein family are highly specific, since other members of
this protein family are not able to compensate for the loss of
Brainiac 1 expression. The phenotype of Brainiac
1 null mice is also strikingly different from phenotypes of mice with targeted deletions of Notch or other components of the
Notch signaling cascade. These animals die at midgestation or later during development (30, 32, 51). However, mice with
targeted deletions of all murine Notch genes have not been
derived. The possibility that Brainiac-dependent glycosylation is
important for the function of all Notch receptors, thus
leading to the more severe phenotype in Brainiac 1 null mice,
cannot be ruled out. It is also possible that
Brainiac-dependent glycoslation is important for the
function of several different receptor types, thus leading to this very
severe phenotype of Brainiac 1 null mice. Since
brainiac shows genetic interaction with the EGF receptor and
the TGF-
homologue gurken in Drosophila, this
pathway is an obvious candidate to be regulated by brainiac or
Brainiac-like molecules in Drosophila and higher organisms.
Genetic evidence in Drosophila indicates that
brainiac shares features with fringe, an
essential gene involved in pattern formation in the fly eye, wing, and
leg. Both genes encode molecules which appear to be involved in
regulating a subset of Notch signaling activities (20,
28). Fringe has been shown to modify the interaction of
Notch, with its ligands Delta and Serrate, by
potentiating the activating effects of Delta but repressing those
of Serrate and thereby giving specificity to the signal (17,
43). Sequence similarities between brainiac and fringe proteins,
which are very weak, can be detected with sensitive motif and profile
searches but not with standard alignment algorithms. Alignment of
Drosophila brainiac and fringe proteins suggests the
existence of a structural motif which is characteristic for procaryotic
and eucaryotic glycosyltransferases (41, 56). Since Notch
and its ligands Delta, Serrate, and Jagged are all glycoproteins,
specific glycosylation events mediated by Brainiac and Fringe
could conceivably modulate Notch-ligand interactions and thereby
regulate signaling events. Recent evidence in Drosophila and
mammalian systems shows that this is true for Fringe:
Fringe-dependent glycosylation of Notch modifies Notch signaling and modulates receptor-ligand interactions (9, 25, 40). It remains to be established whether Brainiac can act
in similar ways to modify signaling in this pathway. Although Fringe and Brainiac appear to catalyze similar
1,3 glycosylation events, the available in vitro data indicate that their substrate specificity is distinct suggesting distinct biological functions of these two
families of proteins (3, 24, 40).
 |
ACKNOWLEDGMENTS |
We thank Oliver Smithies for the targeting vector pOSdupdel. In
addition, we thank Ann Harrington for performing the blastocyst injections and for expert technical assistance with all mouse procedures, Monteserrat Michelmann for help with targeting ES cells and
tissue culture procedures, Jan Pinkas and Nick Chester for helpful
comments on the manuscript, and Katy Mclntyre for editing. We also
thank all members of the Leder lab and the Harvard Medical School
Department of Genetics for helpful comments and suggestions throughout
the project.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Howard Hughes
Medical Institute and Department of Genetics, Harward Medical School, 200 Longwood Ave., Boston, MA 02115. Phone: (617) 432-7667. Fax: (617)
432-7944. E-mail: leder{at}rascal.med.harvard.edu.
Present address: Merck Research Laboratories, West Point, PA 19486.
Present address: Bristol Myers Squibb, Pennington, NJ 08530.
 |
REFERENCES |
| 1.
|
Ahmad, I.,
P. Zaqouras, and S. Artavanis-Tsakonas.
1995.
Involvement of Notch-1 in mammalian retinal neurogenesis: association of Notch-1 activity with both immature and terminally differentiated cells.
Mech. Dev.
53:73-85[CrossRef][Medline].
|
| 2.
|
Amado, M.,
R. Almeida,
F. Carneiro,
S. B. Levery,
E. H. Holmes,
M. Nomoto,
M. A. Hollingsworth,
H. Hassan,
T. Schwientek,
P. A. Nielsen,
E. P. Bennett, and H. Clausen.
1998.
A family of human beta3-galactosyltransferases. Characterization of four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-nacetyl-galactosamine beta-1,3-galactosyltransferase family.
J. Biol. Chem.
273:12770-12778[Abstract/Free Full Text].
|
| 3.
|
Amado, M.,
R. Almeida,
T. Schwientek, and H. Clausen.
1999.
Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions.
Biochim. Biophys. Acta
1473:35-53[Medline].
|
| 4.
|
Artavanis-Tsakonas, S.,
K. Matsuno, and M. E. Fortini.
1995.
Notch signaling.
Science
268:225-232[Abstract/Free Full Text].
|
| 5.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl (ed.).
1997.
Current protocols in molecular biology.
John Wiley and Sons, New York, N.Y.
|
| 6.
|
Bailey, A. M., and J. W. Posakony.
1995.
Suppressor of hairless directly activates transcription of enhancer of split complex genes in response to Notch receptor activity.
Genes Dev.
9:2609-2622[Abstract/Free Full Text].
|
| 7.
|
Bao, Z. Z., and C. L. Cepko.
1997.
The expression and function of Notch pathway genes in the developing rat eye.
J. Neurosci.
17:1425-1434[Abstract/Free Full Text].
|
| 8.
|
Berezovska, O.,
P. McLean,
R. Knowles,
M. Frosh,
F. M. Lu,
S. E. Lux, and B. T. Hyman.
1999.
Notch1 inhibits neurite outgrowth in postmitotic primary neurons.
Neuroscience
93:433-439[CrossRef][Medline].
|
| 9.
|
Bruckner, K.,
L. Perez,
H. Clausen, and S. Cohen.
2000.
Glycosyltransferase activity of Fringe modulates Notch-Delta interactions.
Nature
406:411-415[CrossRef][Medline].
|
| 10.
|
Campbell, R. M.,
M. Metzler,
M. Granovsky,
J. W. Dennis, and J. D. Marth.
1995.
Complex asparagine-linked oligosaccharides in Mgat1-null embryos.
Glycobiology
5:535-543[Abstract/Free Full Text].
|
| 11.
|
Cohen, B.,
A. Bashirullah,
L. Dagnino,
C. Campbell,
W. W. Fisher,
C. C. Leow,
E. Whiting,
D. Ryan,
D. Zinyk,
G. Boulianne,
C. C. Hui,
B. Gallie,
R. A. Phillips,
H. D. Lipshitz, and S. E. Egan.
1997.
Fringe boundaries coincide with Notch-dependent patterning centres in mammals and alter Notch-dependent development in Drosophila.
Nat. Genet.
16:283-288[CrossRef][Medline].
|
| 12.
|
Cole, S. E.,
M. S. Mao,
S. H. Johnston, and T. F. Vogt.
2001.
Identification, expression analysis, and mapping of B3galt6, a putative galactosyltransferase gene with similarity to Drosophila brainiac.
Mamm. Genome
12:177-179[CrossRef][Medline].
|
| 13.
|
de Celis, J. F.,
J. de Celis,
P. Ligoxygakis,
A. Preiss,
C. Delidakis, and S. Bray.
1996.
Functional relationships between Notch, Su(H) and the bHLH genes of the E(spl) complex: the E(spl) genes mediate only a subset of Notch activities during imaginal development.
Development
122:2719-2728[Abstract].
|
| 14.
|
Deng, C.,
A. Wynshaw-Boris,
F. Zhou,
A. Kuo, and P. Leder.
1996.
Fibroblast growth factor receptor 3 is a negative regulator of bone growth.
Cell
84:911-921[CrossRef][Medline].
|
| 15.
|
Deng, C. X.,
A. Wynshaw-Boris,
M. M. Shen,
C. Daugherty,
D. M. Ornitz, and P. Leder.
1994.
Murine FGFR-1 is required for early postimplantation growth and axial organization.
Genes Dev.
8:3045-3057[Abstract/Free Full Text].
|
| 16.
|
Dennis, J. W.,
M. Granovsky, and C. E. Warren.
1999.
Protein glycosylation in development and disease.
Bioessays
21:412-421[CrossRef][Medline].
|
| 17.
|
Fleming, R. J.,
Y. Gu, and N. A. Hukriede.
1997.
Serrate-mediated activation of Notch is specifically blocked by the product of the gene fringe in the dorsal compartment of the Drosophila wing imaginal disc.
Development
124:2973-2981[Abstract].
|
| 18.
|
Goode, S.,
M. Meinick,
T. B. Chou, and N. Perrimon.
1996.
The neurogenic genes egghead and brainiac define a novel signaling pathway essential for epithelial morphogenesis during Drosophila oogenesis.
Development
122:3863-3879[Abstract].
|
| 19.
|
Goode, S.,
M. Morgan,
Y. P. Liang, and A. P. Mahowald.
1996.
Brainiac encodes a novel, putative secreted protein that cooperates with Grk TGF alpha in the genesis of the follicular epithelium.
Dev. Biol.
178:35-50[CrossRef][Medline].
|
| 20.
|
Goode, S., and N. Perrimon.
1997.
Brainiac and fringe are similar pioneer proteins that impart specificity to notch signaling during Drosophila development.
Cold Spring Harbor Symp. Quant. Biol.
62:177-184[Abstract/Free Full Text].
|
| 21.
|
Goode, S.,
D. Wright, and A. P. Mahowald.
1992.
The neurogenic locus brainiac cooperates with the Drosophila EGF receptor to establish the ovarian follicle and to determine its dorsal-ventral polarity.
Development
116:177-192[Abstract].
|
| 22.
|
Greenwald, I.
1998.
LIN-12/Notch signaling: lessons from worms and flies.
Genes Dev.
12:1751-1762[Free Full Text].
|
| 23.
|
Gridley, T.
1997.
Notch signaling in vertebrate development and disease.
Mol. Cell. Neurosci.
9:103-108.
|
| 24.
|
Hennet, T.,
A. Dinter,
P. Kuhnert,
T. S. Mattu,
P. M. Rudd, and E. G. Berger.
1998.
Genomic cloning and expression of three murine UDP-galactose: beta-N-acetylglucosamine beta-1,3-galactosyltransferase genes.
J. Biol. Chem.
273:58-65[Abstract/Free Full Text].
|
| 25.
|
Hicks, C.,
S. H. Johnston,
G. diSibio,
A. Collazo,
T. F. Vogt, and G. Weinmaster.
2000.
Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2.
Nat. Cell Biol.
2:515-520[CrossRef][Medline].
|
| 26.
|
Ihara, Y.,
Y. Sakamoto,
M. Mihara,
K. Shimizu, and N. Taniguchi.
1997.
Overexpression of N-acetylglucosaminyltransferase III disrupts the tyrosine phosphorylation of Trk with resultant signaling dysfunction in PC12 cells treated with nerve growth factor.
J. Biol. Chem.
272:9629-9634[Abstract/Free Full Text].
|
| 27.
|
Ioffe, E., and P. Stanley.
1994.
Mice lacking N-acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates.
Proc. Natl. Acad. Sci. USA
91:728-732[Abstract/Free Full Text].
|
| 28.
|
Irvine, K. D.
1999.
Fringe, Notch, and making developmental boundaries.
Curr. Opin. Genet. Dev.
9:434-441[CrossRef][Medline].
|
| 29.
|
Irvine, K. D., and E. Wieschaus.
1994.
fringe, a Boundary-specific signaling molecule, mediates interactions between dorsal and ventral cells during Drosophila wing development.
Cell
79:595-606[CrossRef][Medline].
|
| 30.
|
Ishibashi, M.,
S. L. Ang,
K. Shiota,
S. Nakanishi,
R. Kageyama, and F. Guillemot.
1995.
Targeted disruption of mammalian hairy and Enhancer of split homolog-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects.
Genes Dev.
9:3136-3148[Abstract/Free Full Text].
|
| 31.
|
Jennings, B.,
A. Preiss,
C. Delidakis, and S. Bray.
1994.
The Notch signalling pathway is required for Enhancer of split bHLH protein expression during neurogenesis in the Drosophila embryo.
Development
120:3537-3548[Abstract].
|
| 32.
|
Jiang, R.,
Y. Lan,
H. D. Chapman,
C. Shawber,
C. R. Norton,
D. V. Serreze,
G. Weinmaster, and T. Gridley.
1998.
Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice.
Genes Dev.
12:1046-1057[Abstract/Free Full Text].
|
| 33.
|
Johnson, J. E.,
K. Zimmerman,
T. Saito, and D. J. Anderson.
1992.
Induction and repression of mammalian achaete-scute homologue (MASH) gene expression during neuronal differentiation of P19 embryonal carcinoma cells.
Development
114:75-87[Abstract].
|
| 34.
|
Kidd, S.,
T. Lieber, and M. W. Young.
1998.
Ligand-induced cleavage and regulation of nuclear entry of Notch in Drosophila melanogaster embryos.
Genes Dev.
12:3728-3740[Abstract/Free Full Text].
|
| 35.
|
Lardelli, M.,
R. Williams, and U. Lendahl.
1995.
Notch-related genes in animal development.
Int. J. Dev. Biol.
39:769-780[Medline].
|
| 36.
|
Laufer, E.,
R. Dahn,
O. E. Orozco,
C. Y. Yeo,
J. Pisenti,
D. Henrique,
U. K. Abbott,
J. F. Fallon, and C. Tabin.
1997.
Expression of Radical fringe in limb-bud ectoderm regulates apical ectodermal ridge formation.
Nature
386:366-373[CrossRef][Medline].
|
| 37.
|
Lecourtois, M., and F. Schweisguth.
1995.
The neurogenic suppressor of hairless DNA-binding protein mediates the transcriptional activation of the enhancer of split complex genes triggered by Notch signaling.
Genes Dev.
9:2598-2608[Abstract/Free Full Text].
|
| 38.
|
Lindsell, C. E.,
J. Boulter,
G. diSibio,
A. Gossler, and G. Weinmaster.
1996.
Expression patterns of Jagged, Delta1, Notch1, Notch2, and Notch3 genes identify ligand-receptor pairs that may function in neural development.
Mol. Cell. Neurosci.
8:14-27[CrossRef][Medline].
|
| 39.
|
Metzler, M.,
A. Gertz,
M. Sarkar,
H. Schachter,
J. W. Schrader, and J. D. Marth.
1994.
Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development.
EMBO J.
13:2056-2065[Medline].
|
| 40.
|
Moloney, D. J.,
V. M. Panin,
S. H. Johnston,
J. Chen,
L. Shao,
R. Wilson,
Y. Wang,
P. Stanley,
K. D. Irvine,
R. S. Haltiwanger, and T. F. Vogt.
2000.
Fringe is a glycosyltransferase that modifies Notch.
Nature
406:369-375[CrossRef][Medline].
|
| 41.
|
Munro, S., and M. Freeman.
2000.
The notch signalling regulator fringe acts in the Golgi apparatus and requires the glycosyltransferase signature motif DXD.
Curr. Biol.
10:813-820[CrossRef][Medline].
|
| 42.
|
Nye, J. S.,
R. Kopan, and R. Axel.
1994.
An activated Notch suppresses neurogenesis and myogenesis but not gliogenesis in mammalian cells.
Development
120:2421-2430[Abstract/Free Full Text].
|
| 43.
|
Panin, V. M.,
V. Papayannopoulos,
R. Wilson, and K. D. Irvine.
1997.
Fringe modulates Notch-ligand interactions.
Nature
387:908-912[CrossRef][Medline].
|
| 44.
|
Priatel, J. J.,
M. Sarkar,
H. Schachter, and J. D. Marth.
1997.
Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction.
Glycobiology
7:45-56[Abstract/Free Full Text].
|
| 45.
|
Robey, E.
1997.
Notch in vertebrates.
Curr. Opin. Genet. Dev.
7:551-557[CrossRef][Medline].
|
| 46.
|
Rodriguez-Esteban, C.,
J. W. Schwabe,
J. De La Pena,
B. Foys,
B. Eshelman, and J. C. Belmonte.
1997.
Radical fringe positions the apical ectodermal ridge at the dorsoventral boundary of the vertebrate limb.
Nature
386:360-366[CrossRef][Medline].
|
| 47.
|
Sestan, N.,
S. Artavanis-Tsakonas, and P. Rakic.
1999.
Contact-dependent inhibition of cortical neurite growth mediated by notch signaling
Science
286:741-746[Abstract/Free Full Text].
|
| 48.
|
Shawber, C.,
J. Boulter,
C. E. Lindsell, and G. Weinmaster.
1996.
Jagged2: a serrate-like gene expressed during rat embryogenesis.
Dev. Biol.
180:370-376[CrossRef][Medline].
|
| 49.
|
Sidow, A.,
M. S. Bulotsky,
A. W. Kerrebrock,
R. T. Bronson,
M. J. Daly,
M. P. Reeve,
T. L. Hawkins,
B. W. Birren,
R. Jaenisch, and E. S. Lander.
1997.
Serrate2 is disrupted in the mouse limb-development mutant syndactylism.
Nature
389:722-725[CrossRef][Medline].
|
| 50.
|
Struhl, G., and A. Adachi.
1998.
Nuclear access and action of notch in vivo.
Cell
93:649-660[CrossRef][Medline].
|
| 51.
|
Swiatek, P. J.,
C. E. Lindsell,
F. F. del Amo,
G. Weinmaster, and T. Gridley.
1994.
Notch1 is essential for postimplantation development in mice.
Genes Dev.
8:707-719[Abstract/Free Full Text].
|
| 52.
|
Weinmaster, G.
1997.
The ins and outs of notch signaling.
Mol. Cell. Neurosci.
9:91-102[CrossRef][Medline].
|
| 53.
|
Xu, T.,
L. A. Caron,
R. G. Fehon, and S. Artavanis-Tsakonas.
1992.
The involvement of the Notch locus in Drosophila oogenesis.
Development
115:913-922[Abstract].
|
| 54.
|
Yoshimura, M.,
Y. Ihara,
Y. Matsuzawa, and N. Taniguchi.
1996.
Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis.
J. Biol. Chem.
271:13811-13815[Abstract/Free Full Text].
|
| 55.
|
Yoshimura, M.,
A. Nishikawa,
Y. Ihara,
S. Taniguchi, and N. Taniguchi.
1995.
Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection.
Proc. Natl. Acad. Sci. USA
92:8754-8758[Abstract/Free Full Text].
|
| 56.
|
Yuan, Y. P.,
J. Schultz,
M. Mlodzik, and P. Bork.
1997.
Secreted fringe-like signaling molecules may be glycosyltransferases.
Cell
88:9-11[CrossRef][Medline].
|
Molecular and Cellular Biology, August 2001, p. 5688-5697, Vol. 21, No. 16
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.16.5688-5697.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Souilhol, C., Cormier, S., Tanigaki, K., Babinet, C., Cohen-Tannoudji, M.
(2006). RBP-J{kappa}-Dependent Notch Signaling Is Dispensable for Mouse Early Embryonic Development.. Mol. Cell. Biol.
26: 4769-4774
[Abstract]
[Full Text]
-
Cormier, S., Le Bras, S., Souilhol, C., Vandormael-Pournin, S., Durand, B., Babinet, C., Baldacci, P., Cohen-Tannoudji, M.
(2006). The Murine Ortholog of Notchless, a Direct Regulator of the Notch Pathway in Drosophila melanogaster, Is Essential for Survival of Inner Cell Mass Cells.. Mol. Cell. Biol.
26: 3541-3549
[Abstract]
[Full Text]
-
Muller, R., Altmann, F., Zhou, D., Hennet, T.
(2002). The Drosophila melanogaster brainiac Protein Is a Glycolipid-specific beta 1,3N-Acetylglucosaminyltransferase. J. Biol. Chem.
277: 32417-32420
[Abstract]
[Full Text]
-
Schwientek, T., Keck, B., Levery, S. B., Jensen, M. A., Pedersen, J. W., Wandall, H. H., Stroud, M., Cohen, S. M., Amado, M., Clausen, H.
(2002). The Drosophila Gene brainiac Encodes a Glycosyltransferase Putatively Involved in Glycosphingolipid Synthesis. J. Biol. Chem.
277: 32421-32429
[Abstract]
[Full Text]
-
Wang, C., Risteli, M., Heikkinen, J., Hussa, A.-K., Uitto, L., Myllyla, R.
(2002). Identification of Amino Acids Important for the Catalytic Activity of the Collagen Glucosyltransferase Associated with the Multifunctional Lysyl Hydroxylase 3 (LH3). J. Biol. Chem.
277: 18568-18573
[Abstract]
[Full Text]